NAV

Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, RNA interference (RNAi), and cell therapy